MedPath

Study of ARO-APOC3 in Adults With Dyslipidemia

Phase 2
Active, not recruiting
Conditions
Dyslipidemias
Interventions
Registration Number
NCT05413135
Lead Sponsor
Arrowhead Pharmaceuticals
Brief Summary

This is an open-label extension of the parent studies AROAPOC3-2001 and AROAPOC3-2002. Adult participants with dyslipidemia who completed the blinded 12-month period from either parent study and continued to meet eligibility criteria had the option to be enrolled into this study. Eligible enrolled participants initially received open-label ARO-APOC3 every three or six months at the assigned dose level of the parent study until a final dose of 25 mg was selected, at which point all participants transitioned to the selected dosing regimen of 25 mg every 3 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
418
Inclusion Criteria
  • Adults who are nonpregnant, nonlactating and do not plan to become pregnant during the study
  • Able and willing to provide written informed consent
  • Completed the 48-week study treatment period in the parent study
Exclusion Criteria
  • Subject was permanently discontinued from ARO-APOC3 in the parent study due to elevated glycated hemoglobin (HbA1c), aspartate aminotransferase (AST) or alanine aminotransferase (ALT)
  • Any new condition or worsening of existing condition or any other situation that would make the subject unsuitable for enrollment, could interfere with the subject participating in or completing the study, would make it difficult to comply with protocol requirements or put the subject at additional safety risk
  • Unwilling to limit alcohol consumption to within moderate limits for the duration of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ARO-APOC3ARO-APOC31 dose of ARO-APOC3 by subcutaneous (sc) injection every 3 months
Primary Outcome Measures
NameTimeMethod
Number of Participants with Treatment-Emergent Adverse Events (TEAEs)Through 24 months
Secondary Outcome Measures
NameTimeMethod
Percent Change from Baseline in Fasting HDL-C Over TimeThrough 24 months
Change from Baseline in Fasting Triglycerides (TG) Over TimeThrough 24 months
Change from Baseline in Fasting Total Apolipoprotein B (ApoB) Over TimeThrough 24 months
Percent Change from Baseline in Fasting Total ApoB Over TimeThrough 24 months
Change from Baseline in Apolipoprotein (Apo) C-III Over TimeThrough 24 months
Change from Baseline in Fasting High-Density Lipoprotein-Cholesterol (HDL-C) Over TimeThrough 24 months
Percent Change from Baseline in Fasting TG Over TimeThrough 24 months
Change from Baseline in Fasting Non-High-Density Lipoprotein-Cholesterol (Non-HDL-C) Over TimeThrough 24 months
Percent Change from Baseline in Fasting Non-HDL-C Over TimeThrough 24 months
Percent Change from Baseline in ApoC-III Over TimeThrough 24 months
Change from Baseline in Fasting Low-Density Lipoprotein-Cholesterol (LDL-C) Over Time Using UltracentrifugationThrough 24 months
Percent Change from Baseline in Fasting LDL-C Over Time Using UltracentrifugationThrough 24 months

Trial Locations

Locations (60)

Westside Medical Associates of Los Angeles

🇺🇸

Beverly Hills, California, United States

Valley Clinical Trials; Inc.

🇺🇸

Northridge, California, United States

Desert Medical Group, Inc.

🇺🇸

Palm Springs, California, United States

Preventive Cardiology Inc.

🇺🇸

Boca Raton, Florida, United States

Invesclinic U,S, LLC

🇺🇸

Fort Lauderdale, Florida, United States

Ocean Blue Medical Research Center Inc.

🇺🇸

Miami Springs, Florida, United States

AppleMed Res Group

🇺🇸

Miami, Florida, United States

A Positive Research, Inc

🇺🇸

Miami, Florida, United States

A&R Research Group

🇺🇸

Pembroke Pines, Florida, United States

Progressive Medical Research

🇺🇸

Port Orange, Florida, United States

Alta Pharmaceutical Research Center

🇺🇸

Dunwoody, Georgia, United States

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

Cardiology Assoc Res LLC

🇺🇸

Tupelo, Mississippi, United States

Methodist Physicians Clinic Heart Consultants

🇺🇸

Omaha, Nebraska, United States

Clinical Res of South Nevada

🇺🇸

Las Vegas, Nevada, United States

NYC Research Inc.

🇺🇸

Long Island City, New York, United States

Mid Hudson Medical Research; PLLC

🇺🇸

New Windsor, New York, United States

Icahn School of Medicine at Mount Sinai (ISMMS)

🇺🇸

New York, New York, United States

Lucas Research, Inc.

🇺🇸

Morehead City, North Carolina, United States

Lillestol Research LLC

🇺🇸

Fargo, North Dakota, United States

Marion Area Health Center

🇺🇸

Marion, Ohio, United States

Advanced Medical Research

🇺🇸

Maumee, Ohio, United States

South Oklahoma Heart Res;LLC

🇺🇸

Oklahoma City, Oklahoma, United States

Tribe Clinical Research

🇺🇸

Greenville, South Carolina, United States

ClinSearch, LLC

🇺🇸

Chattanooga, Tennessee, United States

East Texas Cardiology PA

🇺🇸

Houston, Texas, United States

Baylor College of Medicine

🇺🇸

Houston, Texas, United States

Pioneer Research Solutions, Inc.

🇺🇸

Houston, Texas, United States

BFHC Research

🇺🇸

San Antonio, Texas, United States

Manassas Clinical Research Center

🇺🇸

Manassas, Virginia, United States

Royal Prince Alfred Hospital

🇦🇺

Camperdown, New South Wales, Australia

Core Research Group Pty Ltd

🇦🇺

Milton, Queensland, Australia

USC Clinical Trials - Sippy Downs

🇦🇺

Sippy Downs, Queensland, Australia

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

Monash Health

🇦🇺

Clayton, Victoria, Australia

Genesis Care changing to Advara heartcare

🇦🇺

Joondalup, Western Australia, Australia

Linear Clinical Research

🇦🇺

Nedlands, Western Australia, Australia

LMC Clinical Research Inc

🇨🇦

Concord, Ontario, Canada

Lawson Health Research Institute

🇨🇦

London, Ontario, Canada

Centre d'Etudes Cliniques ECOGENE-21

🇨🇦

Chicoutimi, Quebec, Canada

Institut de Recherches Cliniques de Montreal

🇨🇦

Montréal, Quebec, Canada

Recherche Clinique Sigma Inc

🇨🇦

Québec, Quebec, Canada

DRC Gyogyszervizsgalo Kozpont Balatonfured

🇭🇺

Balatonfüred, Hungary

Belgyogyaszati Kardiologiai Maganrendelo

🇭🇺

Békéscsaba, Hungary

Debreceni Egyetem Klinikai K

🇭🇺

Debrecen, Hungary

Pharma4trial Ltd

🇭🇺

Gyöngyös, Hungary

Selye Janos Korhaz

🇭🇺

Komárom, Hungary

Borbanya Praxis Kft

🇭🇺

Nyíregyháza, Hungary

AMC

🇳🇱

Amsterdam, Netherlands

D and A Research

🇳🇱

Sneek, Netherlands

Albert Schweitzer Ziekenhuis

🇳🇱

Zwijndrecht, Netherlands

Middlemore Clinical Trials

🇳🇿

Papatoetoe, Aukland, New Zealand

NZCR OpCo Ltd

🇳🇿

Christchurch, New Zealand

Southern Clinical Trials Christchurch

🇳🇿

Christchurch, New Zealand

Centrum Medyczne Intercor

🇵🇱

Bydgoszcz, Poland

Medicome Sp. z o.o.

🇵🇱

Oświęcim, Poland

Praktyka Lekarska Ewa Krzyzagorska

🇵🇱

Poznań, Poland

Centrum Medyczne Medyk

🇵🇱

Rzeszów, Poland

Instytut Centrum Zdrowia Matki Polki

🇵🇱

Łódź, Poland

All MED Centrum Medyczne

🇵🇱

Łódź, Poland

© Copyright 2025. All Rights Reserved by MedPath